PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for June 17, 2006 Subscribe to this News Feed    
 

Argentum Medical LLC (Stuart, FL) and Rajat PharmaChem (Mumbai, India) sign MOU for Distribution of Argentum's Silverlon (TM) Wound and Burn Care Product Line in Asia

Argentum Medical LLC and RajatPharma Chem Limited's MOU is for exclusive distribution of Argentum's Silverlon (TM) Wound and Burn Care product line in the Asian market.

Stuart, FL and Mumbai, India (PRWEB) June 17, 2006 -- Argentum Medical LLC of Stuart, FL, and Rajat PharmaChem Ltd of Mumbai, India, have recently signed an MOU for exclusive distribution of Argentum's SilverlonTM wound and burn care product lines in the Asian market.

Argentum Medical LLC, a Delaware Limited Liability Corporation located in Stuart, Florida, is the worlds leading wound, surgical and burn care supplier of FDA Cleared silver medical bandages. Rajat PharmaChem Ltd, of Mumbai, India, is a two hundred million dollar generic pharmaceutical supplier.

Argentum, LLC was the first company to bring silver wound dressings to the market using technology developed by Bart Flick, MD. Dr. Flick's research and clinical studies, beginning in the early 1970's, paved the way for what has become the treatment of choice for wound and burn care in the medical field today. This technology is so effective that even the U.S. Special Forces carry SilverlonTM with them in the field for emergency treatment.

The fast growing Rajat PharmaChem Ltd is an emerging big name among the spectrum of Indian pharmaceutical companies which are spreading their wings across the globe. They offer branded and generic pharmaceutical formulations with or without WHO-GMP/ISO 9000 quality specifications. Products include the full pharmaceutical range in tablets, capsules, soft gelatin capsules,food supplements, liquid orals, injectables and ointments. Mr. K. Arya, Managing Director, said "Thanks to our firm commitment to bringing pharmaceutical products which are 'World Class' and quality standards which equal or exceed the best in the world, we are well established in the international market. We are recognized as a 'One Star Export House' by the Ministry of Commerce, Govt. of India. The synergy of our deal with Argentum will open new avenues in the global market; to compliment and serve both market and mankind."

Argentums CEO, Scott Ty Cobb, put the deal with Rajat together as part of his strategy to take SilverlonTM products into the world marketplace. Mr. Cobb says "This deal is exciting, partnership with a strong company like Rajat will enable us to bring our expertise in wound and burn healing to the Asian market and our products will be readily available within just days, instead of taking weeks to be shipped from the US. The rise in drug resistant microbes makes the need for SilverlonTM technology critically important. It is currently the only wound and burn dressing effective against all bacteria, fungi and viruses, including MRSA's and VRE's. We are sincerely committed to assisting in the relief of suffering and SilverlonTM
is a very powerful tool toward that end."

###

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/WmV0YS1QaWdnLVN1bW0tU2luZy1JbnNlLVplcm8=

Technorati Tags

Bookmark -  Del.icio.us | Furl It | Technorati | Ask | MyWeb | Propeller | Live Bookmarks | Newsvine | TailRank | Reddit | Slashdot | Digg | Stumbleupon | Google Bookmarks | Sphere | Blink It | Spurl


OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareThis
CONTACT INFORMATION
Scott Cobb, Dr. Bart Flick, MD
ARGENTUM MEDICAL LLC
772.403.5861/706.782
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.
 
Close Move